| Karen Ledwith Dedman, MD | |
|
90 Southside Ave, Suite 350, Asheville, NC 28801-4160 | |
| (828) 277-4810 | |
| Not Available |
| Full Name | Karen Ledwith Dedman |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 90 Southside Ave, Asheville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023080454 | NPI | - | NPPES |
| 8928088 | Medicaid | NC | |
| 0170008 | Other | UNITED HEALTHCARE | |
| 28088 | Other | NC | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 27154 (North Carolina) | Primary |
| Entity Name | Inpatient Consultants Of North Carolina Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669422846 PECOS PAC ID: 5991720591 Enrollment ID: O20051012001172 |
News Archive
A clinical trial is under way at Loyola University Health System to evaluate the impact of urge urinary incontinence on a couple's relationship and sex life.
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
The dairy sector in the European Union is an example of how agriculture subsidies can lead to negative health effects in Europe as well as in developing countries.
Two new studies suggest Medicare's system of penalizing hospitals if too many patients are readmitted within 30 days should also look at whether the patients were well enough to remain in their home during that time.
› Verified 3 days ago
| Entity Name | Nm Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366928749 PECOS PAC ID: 3375892060 Enrollment ID: O20200109003016 |
News Archive
A clinical trial is under way at Loyola University Health System to evaluate the impact of urge urinary incontinence on a couple's relationship and sex life.
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
The dairy sector in the European Union is an example of how agriculture subsidies can lead to negative health effects in Europe as well as in developing countries.
Two new studies suggest Medicare's system of penalizing hospitals if too many patients are readmitted within 30 days should also look at whether the patients were well enough to remain in their home during that time.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Ledwith Dedman, MD 90 Southside Ave, Suite 350, Asheville, NC 28801-4160 Ph: () - | Karen Ledwith Dedman, MD 90 Southside Ave, Suite 350, Asheville, NC 28801-4160 Ph: (828) 277-4810 |
News Archive
A clinical trial is under way at Loyola University Health System to evaluate the impact of urge urinary incontinence on a couple's relationship and sex life.
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
The dairy sector in the European Union is an example of how agriculture subsidies can lead to negative health effects in Europe as well as in developing countries.
Two new studies suggest Medicare's system of penalizing hospitals if too many patients are readmitted within 30 days should also look at whether the patients were well enough to remain in their home during that time.
› Verified 3 days ago
Caroline Knox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-4411 Fax: 866-285-9740 | |
John M. Lang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Town Square Blvd, Suite 220, Asheville, NC 28803 Phone: 828-654-5012 Fax: 828-654-5014 | |
Katherine Danielle Lott, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 | |
Dr. Dru Van Wilkes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5854 | |
David A Wells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911 Fax: 828-299-5962 | |
Alan Sol Baumgarten, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-257-4730 |